neobookRx
GuidelinesOther guideline

Women for Referral to the Fetal Medicine Unit

The guidelines recommend management of common obstetric conditions at primary and referral level, based on local experience and evidence-based practice. They are not intended as strict protocols nor as standard operating procedures, but rather as a guide to safe effective management of common obstetric problems. The guidelines should be most useful to interns, medical officers and registrars.

The table below shows categories of women who may be referred to the Fetal Medicine Unit for genetic counseling, detailed scanning, & invasive tests if required. Refer women as early as possible in the pregnancy, to allow time for counseling & decisions, & for early diagnosis of any disorders. CVS is best done at 11-14 weeks & amniocentesis at 15-23 weeks.

Risk factors for genetic disorders and birth defects

Women at risk
Invasive tests
Advanced maternal age (≥40 years)
CVS
 Amniocentesis
Three or more first trimester miscarriages
Parental blood
 Amniocentesis
Previous child with a genetic disorder/birth defect, or family members affected by a specific genetic disorder.
CVS
Amniocentesis
 Cordocentesis
Exposure to teratogen drugs or toxins during pregnancy, e.g. warfarin, retinoids, alcohol, antiepileptic drugs, lithium

Maternal infection during pregnancy
Maternal blood
 Cordocentesis
Maternal illness e.g. pregestational diabetes mellitus, congenital heart conditions, thyroid disease

Couples in consanguineous relationships & women from ethnic groups at high risk for specific recessive disorders, e.g. Ashkenazy Jews (Tay-Sachs), Greeks & Cypriots (thalassaemia) & Central Africans (sickle cell disease)
Parental blood
CVS
 Amniocentesis

Drugs mentioned

NeoHealth® ID 19894 · updated 9/15/2021